DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Brain Organization, Development, and Response to Intervention in Individual Neonates

Not Applicable

Recruiting

Conditions: Development, Infant

Interventions: Behavioral: Neonatal Massage

First Posted Date: 2023-05-06

Last Posted Date: 2025-05-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 80

Registration Number: NCT05843396

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer

Phase 2

Recruiting

Conditions: Breast Cancer
Cancer of the Breast

Interventions: Device: VENTANA MIB-1 Ki67 assay
Device: Oncotype DX® Recurrence Score
Device: PAM50-based Prosigna breast cancer gene signature assay
Drug: Anastrozole
Drug: Combination anthracycline and/or taxane based treatment

First Posted Date: 2023-05-01

Last Posted Date: 2024-08-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 81

Registration Number: NCT05837455

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders

Phase 2

Recruiting

Conditions: Schizophrenia
Treatment Resistant Depression
Aging, Premature

Interventions: Drug: Dasatinib
Drug: quercetin

First Posted Date: 2023-05-01

Last Posted Date: 2025-04-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT05838560

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

CANF-Comb-II PET-MR in Atherosclerosis Multisite

Recruiting

Conditions: Carotid Atherosclerosis
Carotid Artery Atheroma
Asymptomatic Carotid Artery Stenosis

Interventions: Drug: 64Cu-25%-CANF-Comb

First Posted Date: 2023-05-01

Last Posted Date: 2025-04-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 80

Registration Number: NCT05838547

Locations: 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy

Not Applicable

Recruiting

Conditions: Unresectable Solid Tumor
Metastatic Cancer

Interventions: Radiation: Proton GRID Radiotherapy

First Posted Date: 2023-04-26

Last Posted Date: 2025-01-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT05831579

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

ADI-PEG20, Obesity and Prediabetes

Phase 2

Withdrawn

Conditions: PreDiabetes
Obesity

Interventions: Other: Placebo
Biological: ADI-PEG20

First Posted Date: 2023-04-25

Last Posted Date: 2024-11-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 48

Registration Number: NCT05829239

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Phase 2

Recruiting

Conditions: Endometrial Hyperplasia

Interventions: Drug: Placebo
Drug: Semaglutide
Drug: LNG-IUD (Progestin)
Behavioral: Telemedicine behavioral weight program

First Posted Date: 2023-04-25

Last Posted Date: 2025-05-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 96

Registration Number: NCT05829460

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

Phase 1

Withdrawn

Conditions: Recurrent High Grade Uterine Cancer

Interventions: Drug: Paclitaxel
Drug: Batiraxcept

First Posted Date: 2023-04-24

Last Posted Date: 2024-10-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 36

Registration Number: NCT05826015

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
University of Oklahoma, Oklahoma City, Oklahoma, United States

and more 1 locations

North American Prodromal Synucleinopathy Consortium Stage 2

Recruiting

Conditions: Parkinson Disease
REM Sleep Behavior Disorder
Lewy Body Dementia
Dementia With Lewy Bodies
Multiple System Atrophy
REM Sleep Parasomnias

First Posted Date: 2023-04-24

Last Posted Date: 2024-11-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 500

Registration Number: NCT05826457

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

and more 6 locations

Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant

Phase 2

Withdrawn

Conditions: Multiple Myeloma
Myeloma-Associated Amyloidosis

Interventions: Drug: Selinexor
Drug: Lenalidomide
Drug: Dexamethasone

First Posted Date: 2023-04-20

Last Posted Date: 2024-07-10

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT05820763

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy